About Nudge At Nudge, our mission is to develop the best technology for interfacing with the brain to improve peoples lives. Were starting with an approach that we believe can help the most people the fastest,
tl;dr General Proximity is a seed-stage startup developing the next generation of induced proximity medicines (IPMs). Our OmniTAC drug discovery engine furnishes molecules that co-opt existing cellular machinery to overcome therapeutic challenges, which have remained unapproachable
Our Mission Our mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life. For more information, see our website at altoslabs.com. Our Value
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is
Lab Overview Dr. Lisa Ellerbys laboratory at the Buck Institute for Research on Aging investigates the molecular mechanisms underlying age-related neurodegenerative diseases and develops novel small molecule and protein therapeutics for brain aging. We employ a
Molecular Biologist Position: Molecular Biologist Type: Contract Compensation: $70–$90/hour Location: Remote About the Opportunity : This opportunity is for experienced Molecular Biologists with expertise in molecular biology, genetics, gene editing, DNA/RNA analysis, and laboratory research to
Molecular Biologist Position: Molecular Biologist Type: Contract Compensation: $70–$90/hour Location: Remote About the Opportunity : This opportunity is for experienced Molecular Biologists with expertise in molecular biology, genetics, gene editing, DNA/RNA analysis, and laboratory research to
LAB OVERVIEW Dr. Lisa Ellerbys laboratory at the Buck Institute for Research on Aging investigates the molecular mechanisms underlying age-related neurodegenerative diseases and develops novel small molecule and protein therapeutics for brain aging. We employ a
Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including
Molecular Biologist Scientist A Few Words About Us Integrated Resources, Inc is a premier staffing firm recognized as one of the tri-states most well-respected professional specialty firms. IRI has built its reputation on excellent service and
Cell/Molecular Biologist A Few Words About Us Integrated Resources, Inc is a premier staffing firm recognized as one of the tri-states most well-respected professional specialty firms. IRI has built its reputation on excellent service and integrity
Large GP firm recognized in the “Best Law Firms” edition. The Nationally-ranked practices and Metropolitan Tier 1 groups include the firms patent law practice. REQUIREMENTS The ideal candidate will have substantial experience drafting patent applications directed
Work ScheduleStandard (Mon-Fri) Environmental ConditionsAble to lift 40 lbs. without assistance, Adherence to all Good Manufacturing Practices (GMP) Safety Standards, Laboratory Setting Job Description As part of the Thermo Fisher Scientific team, you’ll discover meaningful work
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve
Caribou Biosciences is a leading clinical-stage CRISPR genome‑editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next‑generation genome‑editing technology enables superior precision to develop cell therapies that are armored to potentially improve